Folate and prevention of colorectal cancer in ulcerative colitis

European Journal of Cancer Prevention

Volumn 14, Issue 4, 2005, Pages 395-398

  Biasco, G ^a   Di Marco, M C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Chemoprevention; Colorectal cancer; Folate; Ulcerative colitis

Indexed keywords

FOLIC ACID; MESALAZINE; MESSENGER RNA; PROTEIN P53; SALAZOSULFAPYRIDINE;

ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; DIET SUPPLEMENTATION; DNA DAMAGE; DNA METHYLATION; DNA POLYMORPHISM; HUMAN; META ANALYSIS; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AGE DISTRIBUTION; AGED; CHEMOPREVENTION; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; FOLIC ACID; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 23344454543     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200508000-00013     Document Type: Article

References (55)

1. Allgayer H, Kruis W (2002). Aminosalicylates: potential antineoplastic actions in colon cancer prevention. Scand J Gastroenterol 37: 125-131.
2. Baggott JE, Morgan SL, Ha T, Vaughn WH, Hine RJ (1992). Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs. Biochem J 15: 197-202.
3. Bailey LB, Rampersaud GC, Kauwell GP (2003). Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science. J Nutr 133(Suppl): S1961-S1968.
4. Biasco G, Hakim R. (2002). Commentary. Evidence-Based Oncol 3: 65-66.
5. Biasco G, Zannoni U (1998). Chemoprevention: a new way to face colorectal cancer in ulcerative colitis. Ital J Gastroenterol Hepatol 3: 426-427.
6. Biasco G, Lipkin M, Minarini A, et al. (1984). Proliferative and antigenic properties of rectal cells in patients with chronic ulcerative colitis. Cancer Res 44: 5450-5454.
7. Biasco G, Paganelli GM, Miglioli M, et al. (1990). Rectal cell proliferation and colon cancer risk in ulcerative colitis. Cancer Res 50: 1156-1159.
8. Biasco G, Zannoni U, Paganelli GM, et al. (1997). Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomarkers Prev 6: 469-71.
9. Biasco G, Paganelli GM, Miglioli M, Barbara L (1998). Cell proliferation and kinetics of the gastrointestinal epithelium. In: Si-Chun Ming, Harvey Goldman (editors): Pathology of the Gastrointestinal Tract. Baltimore: Williams & Wilkins, pp. 155-165.
10. Biasco G, Rossini FP, Hakim R, et al. (2002). Cancer surveillance in ulcerative colitis: critical analysis of long-term prospective programme. Dig Liver Dis 34: 339-342.
11. Bird CL, Swendseid ME, Witte JS, et al. (1991). Red cell and plasma folate, folate consumption and the risk of colorectal adenomatous polyps. Cancer Epidemiol 20: 368-374.
12. Butterworth CE, Hatch KD, Goe H, Mueller H, Krundieck CL (1982). Improvement in cervical dysplasia with folic acid therapy in users of oral contraceptives. Am J Clin Nutr 35: 73-82.
13. Carrier J, Medline A, Sohn KJ, et al. (2003). Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2-and beta(2)-micro globulin deficient mice. Cancer Epidemiol Biomarkers Prev 12: 1262-1267.
14. Chen J, Giovannucci E, Kelsey K, et al. (1996). A methylenetetrahydrofolate reductase, polymorphism and risk of colorectal cancer. Cancer Res 56: 4862-4864.
15. Choi SW, Mason JB (2002). Folate status: effect on pathways of colorectal carcinogenesis. J Nutr 132: 243S-318S.
16. Choi SW, Friso S, Dolnikiwski GG, et al. (2003). Biochemical and molecular aberrations in the rat colon due to folate depletion are age-specific. J Nutr 133: 1206-1212.
17. Cravo ML, Albuquerque CM, Salazar de Sousa L, et al. (1998a). Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation. Am J Gastroenterol 93: 2060-2064.
18. Cravo ML, Pinto AG, Chaves P, et al. (1998b). Effect of folate supplementation on DNA methylation of rectal mucosa in patients with colonic adenomas: correlation with nutrient intake. Clin Nutr 17: 45-49.
19. Diculescu M, Ciocirlan M, Pitigoi D, et al. (2003). Folic acid and sulphasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence. Rom J Gastroenterol 12: 283-286.
20. Eaden JA, Mayberry JF (2000). Colorectal cancer complicating ulcerative colitis: a review. Am J Gastroenterol 95: 2710-2719.
21. Eaden JA, Abrams KR, Mayberry JF (2001). The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526-535.
22. Eberhart CE, Coffey PJ, Radhika A, et al. (1994). Up-regulation of cyclooxygenase-2 gene expression in human colorectal and adenocarcinomas. Gastroenterology 107: 1183-1188.
23. Ekazi T, Watanabe M, Inoue N, et al. (2003). A specific genetic alteration on chromosome 6 in ulcerative colitis-associated colorectal cancers. Cancer Res 63: 3747-3749.
24. Ekbom A, Helmick C, Zack M, Adami HO (1990). Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323: 1228-1233.
25. Giovannucci E (2002). Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132(Suppl): S2350-S2355.
26. Giovannucci E, Stampler MJ, Colditz GA, et al. (1998). Multivitamin use, folate and colon cancer in women in the nurse's health study. Ann Intern Med 129: 517-524.
27. Gloria L, Cravo M, Pinto A, et al. (1996). DNA hypomethylation and proliferative activity are increased in rectal mucosa of patients with long-standing ulcerative colitis. Cancer 78: 2300-6.
28. Heimburger DC, Alexander B, Birch R, et al. (1988). Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. JAMA 259: 1525-1530.
29. Khosraviani K, Weir HP, Hamilton P, Moorehead J, Williamson K (2002). Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut 51: 195-199.
30. Kim YI (1999). Folate and carcinogenesis: evidence mechanisms and implications. J Nutr Biochem 10: 66-88.
31. Kim YI (2000). Methylenetetrahydrofolate reductase polymorphisms, folate and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis. Nutr Rev 58: 205-209.
32. Kim YI, Giuliano A, Hatch KD, et al. (1994). Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma. Cancer 74: 893-899.
33. Kim YI, Pogribny IP, Baisnokien AG, et al. (1997). Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumour suppressor gene. Am J Clin Nutr 65: 46-52.
34. Kim YI, Baick HW, Fawaz K, et al. (2001). Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial. Am J Gastroenterol 96: 184-195.
35. Koki AT, Leahy KM, Masferrer JL (1999). Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy. Expert Opin Invest Drugs B: 1623-1638.
36. Kvist N, Jacobsen O, Kvist HK, et al. (1989). Malignancy in ulcerative colitis. Scand J Gastroenterol 24: 497-506.
37. Lashner BA (1993). Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 119: 549-554.
38. Lashner BA, Heidenreich PA, Su GL, Kane SWV, Hanauer SB (1989a). Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology 97: 255-259.
39. Lashner BA, Silverstein MJ, Hanauer SB. (1989b). Hazard rates for dysplasia and cancer in ulcerative colitis: results from a surveillance program. Dig Dis Sci 34: 1536-1541.
40. Lashner BA, Provencher KS, Seidner DL, Knesebeck A, Brzezinki A (1997). The effect of folic acid supplementation on the risk for cancer dysplasia in ulcerative colitis. Gastroenterology 112: 29-32.
41. Lashner BA, Shapiro BD, Husain A, Goldblum JR (1999). Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am J Gastroenterol 94: 456-462.
42. Lennard Jones JE (1985). Cancer risk in ulcerative colitis: surveillance or surgery. Br J Surg 72(Suppl): S84-S86.
43. Lipkin M (1988). Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res 48: 235-245.
44. 3H-thymidine labeling pattern in colonic epithelial cells. Cancer Res 44: 4201-4207.
45. Ma J, Stempfer Mj, Giovannucci E, et al. (1997). Methylenetetrahydrofolate reductase polymorphism and the risk colorectal cancer. Cancer Res 57: 1098-1102.
46. Melville DM, Jass JR, Shepherd NA. (1988). Dysplasia and deoxyribonucleic acid aneuploidy in the assessment of precancerous changes in chronic ulcerative colitis. Gastroenterology 95: 668-675.
47. Mouzas IA, Papavassiliou ED, Kotroubakis I (1998). Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role of folate. Ital J Gastroenterol Hepatol 3: 421-425.
48. Paganelli GM, Higgins PJ, Biasco G, et al. (1993). Abnormal rectal cell proliferation and p52/p53 protein expression in patients with ulcerative colitis. Cancer Lett 73: 23-28.
49. Reisenhauer AM, Halsted CH (1981). Human jejunal brush border folate conjugate. Characteristics and inhibition by salicylazosulfapyridine. Biochim Biophys Acta 659: 62-69.
50. Ricciardiello L, Goel A, Mantovani V, et al. (2003). Frequent loss of hMLH1 by promoter hypermethylation lead microsatellite instability in adenomatous polyps of patients with single first-degree member affected by colon cancer. Cancer Res 63: 787-792.
51. Riddell RH, Goldman H, Ransohoff DF, et al. (1983). Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical implications. Hum Pathol 14: 931-968.
52. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M (1997). Methylenetetrahydrofolate reductase, diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 8: 513-518.
53. Sohn KJ, Stempac JM, Reid S, et al. (2003). The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon. Carcinogenesis 24: 81-90.
54. Ulrich CM, Kampman E, Bigler J, et al. (1999). Colorectal adenomas and the C677T MTHFR polymorphism evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev 8: 659-668.
55. Vogelstein B, Fearon ER, Hamilton SR, et al. (1988). Genetic alterations during colorectal tumour development. N Engl J Med 319: 525-532.